BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27216827)

  • 1. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.
    Cheng DR; Barton R; Greenway A; Crawford NW
    Expert Rev Vaccines; 2016 Dec; 15(12):1567-1574. PubMed ID: 27216827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccinations in patients with autoimmune diseases].
    Bühler S; Hatz C
    Ther Umsch; 2016; 73(5):275-80. PubMed ID: 27268452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing immunization in pediatric special risk groups.
    Crawford NW; Bines JE; Royle J; Buttery JP
    Expert Rev Vaccines; 2011 Feb; 10(2):175-86. PubMed ID: 21332267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine administration in children with chronic kidney disease.
    Esposito S; Mastrolia MV; Prada E; Pietrasanta C; Principi N
    Vaccine; 2014 Nov; 32(49):6601-6. PubMed ID: 25275950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination under immunosuppressive therapy of chronic inflammatory diseases].
    Weisser M
    Internist (Berl); 2011 Mar; 52(3):277-82. PubMed ID: 21152884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-preventable diseases in Europe: where do we stand?
    Wicker S; Maltezou HC
    Expert Rev Vaccines; 2014 Aug; 13(8):979-87. PubMed ID: 24958075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and routine childhood immunization: a review.
    Clements CJ; von Reyn CF; Mann JM
    Bull World Health Organ; 1987; 65(6):905-11. PubMed ID: 3325188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of children with secondary immunodeficiency.
    Esposito S; Prada E; Lelii M; Castellazzi L
    Hum Vaccin Immunother; 2015; 11(11):2564-70. PubMed ID: 26176360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult immunization in India: Importance and recommendations.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2015; 11(9):2180-2. PubMed ID: 25483654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giving rituximab in patients with occult or resolved hepatitis B virus infection: are the current guidelines good enough?
    Civan J; Hann HW
    Expert Opin Drug Saf; 2015 Jun; 14(6):865-75. PubMed ID: 25826452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical review of immunizations in adult patients with cancer.
    Ariza-Heredia EJ; Chemaly RF
    Hum Vaccin Immunother; 2015; 11(11):2606-14. PubMed ID: 26110220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.
    Rondaan C; Furer V; Heijstek MW; Agmon-Levin N; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; van Assen S; Elkayam O
    RMD Open; 2019; 5(2):e001035. PubMed ID: 31565247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult immunization and its impact on children.
    Boyle DP; Flaherty JP
    Pediatr Ann; 2013 Aug; 42(8):159-63. PubMed ID: 23910029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity in vaccine-preventable infections in the Russian Federation and measures aimed at their decrease and eradication].
    Onishchenko GG
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (2):16-28. PubMed ID: 12886602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.
    Danza A; Ruiz-Irastorza G
    Lupus; 2013 Oct; 22(12):1286-94. PubMed ID: 24098001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccinations for immunocompromised hosts – focussing on patients after a hematological stem cell or organ transplantation, with HIV or with functional or anatomical asplenia].
    Staehelin C; Hirzel C; Hauser C; Furrer H
    Ther Umsch; 2016; 73(5):281-9. PubMed ID: 27268453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The weight of obesity on the human immune response to vaccination.
    Painter SD; Ovsyannikova IG; Poland GA
    Vaccine; 2015 Aug; 33(36):4422-9. PubMed ID: 26163925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.